The Valley Desk

NCT06193889 · Interventional trial

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions Generalized Myasthenia Gravis, Myasthenia Gravis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov